Shares of Cencora Inc. COR slid 2.56% to $254.00 Wednesday, on what proved to be an all-around mixed trading session for the ...

With a market cap of $50.5 billion, Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a global healthcare solutions ...

We recently published a list of 10 Stocks With At Least $30 Million In Insider Sales Recently. In this article, we are going ...

Cencora (NYSE:COR) has made headlines with its announcement on March 10, 2025, detailing plans for strategic acquisitions and investments in technology infrastructure, aiming to drive future growth.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Cencora offers steady revenue growth from pharmaceutical distribution, benefiting from rising healthcare demand and an aging ...

John Arena is interim president of global pharma services at Cencora, managing a team that offers a broad range of solutions ...

Shares of Cencora Inc. COR advanced 1.82% to $253.54 Friday, on what proved to be an all-around favorable trading session for ...

Argus analyst David Toung raised the firm’s price target on Cencora (COR) to $280 from $270 and keeps a Buy rating on the shares. The company ...

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.

In early January, the company formerly known as AmerisourceBergen, which owns and operates Besse Medical, purchased Retina ...